RATIONALE: Accumulating evidence for the presence of GABA(A) ρ receptors within the amygdala which differ from other members of the GABA(A) receptor family in both subunit composition and functional properties has been recently obtained. OBJECTIVES: This work was conducted to study whether GABA(A) ρ receptors may have a putative role in the amygdaloid modulation of fear and anxiety. RESULTS: It was found that the bilateral intra-amygdaloid administration (6-240 pmol/side) of (1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid, a selective GABA(A) ρ receptor antagonist, reduced dose-dependently the exploration of the open arms of the elevated plus-maze without affecting locomotion and increased the plasma levels of corticosterone. In contrast, bicuculline in the dose range used (1.8-60 pmol/side) induced seizures, but had no effects on the exploration of the maze. CONCLUSIONS: It is suggested that GABA(A) ρ receptors may have a role in the amygdaloid modulation of fear and anxiety.
RATIONALE: Accumulating evidence for the presence of GABA(A) ρ receptors within the amygdala which differ from other members of the GABA(A) receptor family in both subunit composition and functional properties has been recently obtained. OBJECTIVES: This work was conducted to study whether GABA(A) ρ receptors may have a putative role in the amygdaloid modulation of fear and anxiety. RESULTS: It was found that the bilateral intra-amygdaloid administration (6-240 pmol/side) of (1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid, a selective GABA(A) ρ receptor antagonist, reduced dose-dependently the exploration of the open arms of the elevated plus-maze without affecting locomotion and increased the plasma levels of corticosterone. In contrast, bicuculline in the dose range used (1.8-60 pmol/side) induced seizures, but had no effects on the exploration of the maze. CONCLUSIONS: It is suggested that GABA(A) ρ receptors may have a role in the amygdaloid modulation of fear and anxiety.
Authors: Abraham Rosas-Arellano; Lenin David Ochoa-de la Paz; Ricardo Miledi; Ataúlfo Martínez-Torres Journal: Neurosci Res Date: 2006-12-22 Impact factor: 3.304
Authors: Miguel Pérez de la Mora; Kirsten X Jacobsen; Minerva Crespo-Ramírez; Candy Flores-Gracia; Kjell Fuxe Journal: Neurochem Res Date: 2008-05-13 Impact factor: 3.996
Authors: Stephanie A Heusser; Özge Yoluk; Göran Klement; Erika A Riederer; Erik Lindahl; Rebecca J Howard Journal: J Neurochem Date: 2016-05-25 Impact factor: 5.372
Authors: Yuri A Blednov; Jillian M Benavidez; Mendy Black; Courtney R Leiter; Elizabeth Osterndorff-Kahanek; David Johnson; Cecilia M Borghese; Jane R Hanrahan; Graham A R Johnston; Mary Chebib; R Adron Harris Journal: PLoS One Date: 2014-01-16 Impact factor: 3.240
Authors: Lenin David Ochoa-de la Paz; Martin González-Andrade; Herminia Pasantes-Morales; Rodrigo Franco; Rubén Zamora-Alvarado; Edgar Zenteno; Hugo Quiroz-Mercado; Roberto Gonzales-Salinas; Rosario Gulias-Cañizo Journal: BMC Neurosci Date: 2018-08-03 Impact factor: 3.288